LDLR and Hypercholesterolemia: Concurrently, we injected the mice weekly with either a control antisense oligonucleotide (ASO) or an ASO specifically targeting LDL receptor (Ldlr-ASO) in the liver to create conditions of hypertriglyceridemia and hypercholesterolemia (33) (Figure 1A).